From first human dose to real-world patients.
From Phase I–IV trials to bioequivalence (BA/BE) studies, Caco-2 permeability, IVRT, and IVPT, we deliver full-service clinical execution with GCP monitoring and data integrity audits.
Scientifically robust, regulatory-ready protocols.
Global clinical trial network.
IEC/IRB and health authority submissions.
Including specialised permeability (Caco-2), IVRT, IVPT.
From FIH to post-marketing.
GCP compliance, data integrity checks.
EDC setup, data cleaning, statistical interpretation.